Anti-müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis

van der Ham, Kim; Laven, Joop S.E.; Tay, Chau Thien; Mousa, Aya; Teede, Helena; Louwers, Yvonne V.

doi:10.1016/j.fertnstert.2024.05.163

Fertility and Sterility

2024

DOI: 10.1016/j.fertnstert.2024.05.163

|View full text |Cite

Anti-müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis

Kim van der Ham,

Joop S.E. Laven,

Chau Thien Tay

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 105 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Elevated antimüllerian hormone level is useful in making the diagnosis of polycystic ovarian morphology and likely one day the diagnosis of polycystic ovary syndrome

Seifer

2024

Fertility and Sterility

View full text Add to dashboard Cite

Elevated antimüllerian hormone level is useful in making the diagnosis of polycystic ovarian morphology and likely one day the diagnosis of polycystic ovary syndrome

Seifer

2024

Fertility and Sterility

View full text Add to dashboard Cite

Polycystic ovarian morphology: the number of chocolate chips is more important than the size of the cookie

Quaas

2024

Fertility and Sterility

View full text Add to dashboard Cite

Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications

Briceño Silva,

Thomas Garcia,

Ajamyan

et al. 2024

Cureus

View full text Add to dashboard Cite

Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder affecting women of reproductive age, with significant implications for cardiometabolic health. This review focuses on the relationship between PCOS and hypertension (HTN), an area that remains underexplored despite growing evidence of its importance. PCOS is characterized by hyperandrogenism (HA), ovulatory dysfunction, and polycystic ovarian morphology (PCOM), all of which contribute to a complex metabolic profile that includes insulin resistance (IR), obesity, and dyslipidemia. These factors collectively exacerbate the risk of HTN. Emerging research suggests HA in PCOS may directly influence the renin-angiotensin system (RAS), increasing blood pressure by promoting sodium retention and vascular tone. Additionally, IR, prevalent in both lean and obese women with PCOS, further contributes to HTN by enhancing sympathetic nervous system activity and impairing endothelial function. Despite these associations, the direct link between PCOS and HTN has not been definitively established, warranting further investigation. This review synthesizes current knowledge on the etiology of PCOS and its metabolic consequences, highlighting the need for targeted research to clarify the mechanisms linking PCOS with HTN. Understanding these pathways is crucial for improving the management of PCOS and reducing cardiovascular risks in affected women. By addressing these gaps, this review underscores the importance of considering HTN as a significant comorbidity in PCOS and calls for more comprehensive studies to guide clinical practice.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Anti-müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis

Cited by 3 publications

References 105 publications

Elevated antimüllerian hormone level is useful in making the diagnosis of polycystic ovarian morphology and likely one day the diagnosis of polycystic ovary syndrome

Elevated antimüllerian hormone level is useful in making the diagnosis of polycystic ovarian morphology and likely one day the diagnosis of polycystic ovary syndrome

Polycystic ovarian morphology: the number of chocolate chips is more important than the size of the cookie

Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications

Contact Info

Product

Resources

About